News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17923)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
AxoGen to Host Second Annual Analyst and Investor Day on November 20, 2017
AxoGen executives and surgeon thought leaders will discuss the company’s comprehensive platform for peripheral nerve repair and the emerging nerve repair market.
November 7, 2017
·
4 min read
Business
Curis Reports Third Quarter 2017 Financial Results
Management to host conference call today at 8:30 a.m. EST.
November 7, 2017
·
13 min read
Business
Aclaris Therapeutics Reports Third Quarter 2017 Financial Results
As of September 30, 2017, Aclaris had aggregate cash, cash equivalents and marketable securities of $227.8 million compared to $174.1 million as of December 31, 2016.
November 7, 2017
·
12 min read
Business
Cogentix Medical Reports Third Quarter Results; Second Highest Quarterly Revenue in Company History
Third quarter revenue was $13.8M, an increase of 3% over the third quarter of 2016.
November 7, 2017
·
31 min read
Business
Kindred Biosciences Announces Third Quarter 2017 Financial Results
Kindred Biosciences today announced financial results for the third quarter ended September 30, 2017 and provided updates on its programs.
November 7, 2017
·
11 min read
Business
Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results
Total net product sales from HETLIOZ and Fanapt were $41.3M in the third quarter of 2017, a 2% decrease compared to $42.1M in the second quarter of 2017 and a 7% increase compared to $38.5M in the third quarter of 2016.
November 7, 2017
·
28 min read
Business
Theravance Biopharma Reports Third Quarter 2017 Financial Results and Provides Business Update
Revenue for the third quarter of 2017 was $4.3M.
November 7, 2017
·
19 min read
Business
Cumberland Pharma Reports 27% Revenue Growth in the Third Quarter
Cumberland Pharma announced third quarter 2017 financial results with Net Revenues of $11.2M, up 27% over the prior year quarter.
November 7, 2017
·
33 min read
Business
DelMar Pharma Appoints Saiid Zarrabian as Interim Chief Executive Officer
Mr. Zarrabian is a highly successful industry veteran.
November 7, 2017
·
5 min read
Business
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2017
Cash and investments in marketable securities at September 30, 2017 were $412.2M as compared to $389.1M at December 31, 2016.
November 7, 2017
·
26 min read
Previous
20 of 30
Next